...
首页> 外文期刊>Annual review of biomedical engineering. >Biomaterial Strategies for Immunomodulation
【24h】

Biomaterial Strategies for Immunomodulation

机译:免疫调节的生物材料策略

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Strategies to enhance, suppress, or qualitatively shape the immune response are of importance for diverse biomedical applications, such as the development of new vaccines, treatments for autoimmune diseases and allergies, strategies for regenerative medicine, and immunotherapies for cancer. However, the intricate cellular and molecular signals regulating the immune system are major hurdles to predictably manipulating the immune response and developing safe and effective therapies. To meet this challenge, biomaterials are being developed that control how, where, and when immune cells are stimulated in vivo, and that can finely control their differentiation in vitro. We review recent advances in the field of biomaterials for immunomodulation, focusing particularly on designing biomaterials to provide controlled immunostimulation, targeting drugs and vaccines to lymphoid organs, and serving as scaffolds to organize immune cells and emulate lymphoid tissues. These ongoing efforts highlight the many ways in which biomaterials can be brought to bear to engineer the immune system.
机译:增强,抑制或定性塑造免疫应答的策略对于各种生物医学应用都很重要,例如新疫苗的开发,自身免疫性疾病和过敏的治疗,再生医学的策略以及癌症的免疫疗法。然而,调节免疫系统的复杂细胞和分子信号是可预测地操纵免疫反应和开发安全有效疗法的主要障碍。为了应对这一挑战,正在开发生物材料,该材料可控制在体内刺激免疫细胞的方式,位置和时间,并可以在体外很好地控制其分化。我们回顾了免疫调节生物材料领域的最新进展,特别侧重于设计可提供受控免疫刺激的生物材料,将药物和疫苗靶向淋巴器官,并用作组织免疫细胞和模拟淋巴组织的支架。这些正在进行的努力突显了可以利用多种生物材料来改造免疫系统的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号